Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-3254
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077 ; day:12 ; month:2 ; year:2020 ; pages:1-12
Aids and behavior ; (12.2.2020), 1-12
- Urheber
-
Tolley, Elizabeth E.
Zangeneh, Sahar Z.
Chau, Gordon
Eron, Joe
Grinsztejn, Beatriz
Humphries, Hilton
Liu, Albert
Siegel, Marc
Bertha, Maseko
Panchia, Ravindre
Li, Sue
Cottle, Leslie
Rinehart, Alex
Margolis, David
Jennings, Andrea
McCauley, Marybeth
Landovitz, Raphael J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10461-020-02808-2
- URN
-
urn:nbn:de:101:1-2020050919050169184264
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tolley, Elizabeth E.
- Zangeneh, Sahar Z.
- Chau, Gordon
- Eron, Joe
- Grinsztejn, Beatriz
- Humphries, Hilton
- Liu, Albert
- Siegel, Marc
- Bertha, Maseko
- Panchia, Ravindre
- Li, Sue
- Cottle, Leslie
- Rinehart, Alex
- Margolis, David
- Jennings, Andrea
- McCauley, Marybeth
- Landovitz, Raphael J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
CAB
Cab
CAB
CAB
CAB
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
CAB
Cab
CAB
CAB
CAB
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
CAB
Cab
CAB
CAB
CAB
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors